GLENMARK NSE
Glenmark Pharmaceuticals Share Price
Price chart
No chart data available for this instrument.
Market depth
| Bid price | Qty |
|---|---|
| 0.00 | 0 |
| — | — |
| — | — |
| — | — |
| — | — |
| Bid total | — |
| Ask price | Qty |
|---|---|
| 2,441.50 | 4,006 |
| — | — |
| — | — |
| — | — |
| — | — |
| Ask total | — |
Performance
Today's low 2,292.00
Today's high 2,441.50
52 week low 1,792.60
52 week high 2,537.60
- Open price
- 2,330.40
- Previous close
- 2,325.70
- Volume
- 12,77,155
- Avg. price
- 2,354.52
- Lower circuit
- 2,197.40
- Upper circuit
- 2,685.60
Shareholding pattern
Quarter ended 30 Jun 2026
- Promoter & Promoter Group
- 46.65%
- Public
- 53.35%
From the company's shareholding pattern filing with NSE.
News
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals trades on the NSE main board under the symbol GLENMARK. The GLENMARK share price on this page is live during market hours, alongside the order book, the day's range and the company's latest disclosed shareholding.
Over the past year the share has moved between ₹1,792.6 and ₹2,537.6. At ₹2,441.5 it is 3.8% below the 52-week high, placing it in the upper half of that range.
As of the filing for 30 Jun 2026, promoters held 46.65% of Glenmark Pharmaceuticals and public shareholders 53.35%, making it a company where promoters hold a significant but non-controlling stake.
12.77 lakh shares changed hands in the latest session worth roughly ₹300.71 crore at the average traded price. Traded volume is a rough guide to how easily a position can be entered or exited.
Key facts
- 52-week high
- ₹2,537.6
- 52-week low
- ₹1,792.6
- Promoter holding
- 46.65%
- Public holding
- 53.35%
- Shareholding as of
- 30 Jun 2026
- Volume (latest session)
- 12.77 lakh
- Previous close
- ₹2,325.7
- Day range
- ₹2,292 – ₹2,441.5
- Symbol
- GLENMARK
- Exchange
- NSE
Prices are sourced from the exchanges and shown for information only. They may be delayed and should not be relied on for trading decisions. Investments in securities are subject to market risk; read all related documents carefully before investing.
